{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 51985
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10005428",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "2",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140312",
      "fulfillexpeditecriteria": "2",
      "companynumb": "US-ASTRAZENECA-2013SE85964",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "ASTRAZENECA",
        "duplicatenumb": "US-ASTRAZENECA-2013SE85964"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Eczema",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "CASODEX",
            "drugauthorizationnumb": "020498",
            "drugdosagetext": "DAILY",
            "drugdosageform": "TABLET",
            "drugadministrationroute": "048",
            "drugindication": "PROSTATIC SPECIFIC ANTIGEN INCREASED",
            "drugstartdateformat": "602",
            "drugstartdate": "2013",
            "actiondrug": "4",
            "openfda": {
              "application_number": [
                "NDA020498"
              ],
              "brand_name": [
                "CASODEX"
              ],
              "generic_name": [
                "BICALUTAMIDE"
              ],
              "manufacturer_name": [
                "ANI Pharmaceuticals, Inc."
              ],
              "product_ndc": [
                "62559-680"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "BICALUTAMIDE"
              ],
              "rxcui": [
                "108828",
                "199123"
              ],
              "spl_id": [
                "9395c6cd-8f49-423e-839b-0c3aeb89b371"
              ],
              "spl_set_id": [
                "dfee4fe7-8478-4a3e-925d-00be3cd0ab67"
              ],
              "package_ndc": [
                "62559-680-30"
              ],
              "nui": [
                "N0000000243",
                "N0000175560"
              ],
              "pharm_class_moa": [
                "Androgen Receptor Antagonists [MoA]"
              ],
              "pharm_class_epc": [
                "Androgen Receptor Inhibitor [EPC]"
              ],
              "unii": [
                "A0Z3NAU9DP"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ELIGARD",
            "drugdosagetext": "UNKNOWN Q4MONTHS",
            "drugadministrationroute": "050",
            "drugindication": "PROSTATE CANCER",
            "openfda": {
              "application_number": [
                "NDA021379",
                "NDA021488",
                "NDA021731",
                "NDA021343"
              ],
              "brand_name": [
                "ELIGARD"
              ],
              "generic_name": [
                "LEUPROLIDE ACETATE"
              ],
              "manufacturer_name": [
                "TOLMAR Inc."
              ],
              "product_ndc": [
                "62935-223",
                "62935-753",
                "62935-303",
                "62935-453",
                "62935-227",
                "62935-756",
                "62935-306",
                "62935-461"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "rxcui": [
                "752884",
                "752889",
                "752894",
                "752899",
                "825325",
                "825333",
                "825334",
                "825335"
              ],
              "spl_id": [
                "2bea4c81-66a2-4817-9440-5f5da8dea04a",
                "58cff066-4345-4624-8868-4c232a051a5d"
              ],
              "spl_set_id": [
                "b78d1919-9dee-44fa-90f9-e0a26d32481d",
                "b7b679a9-6823-4ef8-8d31-3ab5058ffcfc"
              ],
              "package_ndc": [
                "62935-753-75",
                "62935-754-74",
                "62935-755-75",
                "62935-223-05",
                "62935-221-04",
                "62935-224-05",
                "62935-303-30",
                "62935-305-29",
                "62935-304-30",
                "62935-453-45",
                "62935-454-44",
                "62935-455-45",
                "62935-756-80",
                "62935-306-40",
                "62935-227-10",
                "62935-461-50"
              ],
              "substance_name": [
                "LEUPROLIDE ACETATE"
              ],
              "unii": [
                "37JNS02E7V"
              ]
            }
          }
        ]
      }
    }
  ]
}